• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Extrovis` Sugammadex Receives Approval in Europe

    EMA

    Extrovis` Lacosamide Adroiq (lacosamide) Receives Approval in Europe

    EMA

    Megasoft completed the acquisition of 40% stake in Extrovis AG.

    MARKET SCREENER

    Megasoft Limited agreed to acquire 40% stake in EXTROVIS AG for $16 million.

    MARKETSCREENER

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.